Biomednewsbreaks - Briacell Therapeutics Corp. (NASDAQ: BCTX) (TSX: BCT) Announces Pricing ...
BriaCell (NASDAQ: BCTX, BCTXW) (TSX: BCT) , a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, has ...
BriaCell Therapeutics (NASDAQ:BCTX) Price Target Raised to $32.00
BriaCell Therapeutics (NASDAQ:BCTX – Get Free Report) had its price target lifted by investment analysts at HC Wainwright from $15.00 to $32.00 in a research note issued to investors on ...
H.C. Wainwright raises Briacell stock target to $32 on trial success
H.C. Wainwright analyst Emily Bodnar increased the price target for Briacell Therapeutics (NASDAQ:BCTX) to $32 from the previous $15, while maintaining a Buy rating on the stock. The company, ...
H.C. Wainwright因试验成功将Briacell目标股价上调至32美元
周二，H.C. Wainwright分析师Emily Bodnar将Briacell Therapeutics (NASDAQ: BCTX ...